Pancreatic Cancer Research

ResearcherKAN Research InstituteActive in the last 2 years

Ken Sasai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6068-051X; OpenAlex author ID A5024422810. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 3

  1. Cultures derived from pancreatic cancer xenografts with long-term gemcitabine treatment produce chemoresistant secondary xenografts: Establishment of isogenic … Last author DOI 10.1016/j.prp.2024.155632↗
  2. Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41556-024-01498-5↗
  3. Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patients. Last author DOI 10.1097/mpa.0000000000001438↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tomoo Itoh · 2 shared papers, 2019–2024 · strength 0.36
  2. Yasuyo Kobayashi-Ooka · 1 shared paper, 2024 · strength 0.26
  3. Akihito Machinaga · 2 shared papers, 2019–2024 · strength 0.25
  4. Eisuke Iwasaki · 1 shared paper, 2024 · strength 0.15
  5. Toshiro Sato · 1 shared paper, 2024 · strength 0.15
  6. Takanori Kanai∥ · 1 shared paper, 2024 · strength 0.15
  7. Hiroki Tamagawa · 1 shared paper, 2024 · strength 0.15
  8. Minoru Kitago · 1 shared paper, 2024 · strength 0.15
  9. Hiroshi Seno · 1 shared paper, 2024 · strength 0.15
  10. Yuko Kitagawa · 1 shared paper, 2024 · strength 0.15
  11. Yuzo Kodama · 1 shared paper, 2024 · strength 0.15
  12. Yuichi Hori · 1 shared paper, 2019 · strength 0.10
  13. Kazuya Shimizu · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.